Residential PM2.5 during induction was associated with positive EOI MRD in patients with NCI high-risk B-ALL and this findings contribute to a growing body of evidence that environmental exposures are associated with inferior outcomes among children diagnosed with ALL.
Abstract
Background
In acute lymphoblastic leukemia (ALL), minimal residual disease (MRD) is an established biomarker of treatment response and strongly associated with poor outcomes. Among children with ALL, air pollution has been associated with lower survival but has not been evaluated with prognostic biomarkers like end of induction (EOI) MRD.
Methods
Using the Reducing Ethnic Disparities in Acute Leukemia (REDIAL) Consortium, we analyzed 2,125 pediatric patients with ALL. Daily fine particulate matter (PM2.5) estimates were obtained from the Centers for Disease Control and Prevention and linked to patients' residential and treatment center census tracts. Mean daily PM2.5 during induction was calculated using two definitions: 1) based solely on patients' residential address, and 2) Days 1-7 based on the treatment center and Days 8 to EOI on patients' residence. Patients were categorized in quartiles based on mean daily PM2.5. EOI MRD ≥0.1% or ≥ 0.01% was considered positive. Adjusted odds ratios (aORs) and 95% confidence intervals (CIs) were calculated using logistic regression.
Results
In B-ALL, mean daily residential PM2.5 during induction was associated with positive EOI MRD in quartiles 2 (aOR: 1.56, 95% CI: 1.08, 2.24) and 3 (aOR: 1.51, 95% CI: 1.05, 2.17) but not quartile 4 (aOR: 1.19). The association across all three quartiles strengthened when restricted to NCI high-risk B-ALL (aOR range: 1.73-2.28).
Conclusions
Residential PM2.5 was associated with positive EOI MRD in patients with NCI high-risk B-ALL. Our findings contribute to a growing body of evidence that environmental exposures are associated with inferior outcomes among children diagnosed with ALL.
Importance
Exposure to fine particulate matter with an aerodynamic diameter of 2.5 µm or less (PM2.5) has been associated with multiple malignant neoplasms, but its relationship with sinonasal malignant neoplasm (SNM) remains poorly characterized.
Objective
To evaluate the association between regional PM2.5 exposure...
Hong-Ho Yang, P. Hwang, Karl O'Sharkey et al.· JAMA Otolaryngology - Head a...· 0 citations
Relapsed pediatric acute lymphoblastic leukemia (ALL) confers an unfavorable prognosis. We evaluated the outcomes of an arsenic trioxide (ATO)-incorporating chemotherapy protocol in pediatric first-relapsed ALL.
Patients were risk-stratified according to the ALL-REZ BFM 2002 protocol. Group A received an ins...
Jia-Nan Li, Ji-Xun Lin, Cui-Yun Yang et al.· Frontiers in Oncology· 0 citations
Survival of adults with ALL in Latin America has improved compared with historical reports, but substantial disparities persist between public and private settings, and upfront dasatinib was associated with improved OS, primarily through lower non-relapse mortality rather than reduced relapse incidence.
W. F. Silva, M. Espinoza, L. Ferrari et al.· The Lancet Regional Health -...· 0 citations
Abstract Introduction Acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy. Although survival outcomes have improved, renal impairment remains a clinically significant yet underrecognized complication. Objective This study aimed to evaluate early renal function changes in children with ALL from di...
Meghna Singh, Neha Goel, Vaishnavi Sreenivasan et al.· Indian Journal of Medical an...· 0 citations
End-of-induction measurable residual disease (EOI-MRD) predicts poor outcomes in B-lineage acute lymphoblastic leukemia (B-ALL). While MRD positivity is conventionally defined at ≥0.01%, data regarding the prognostic relevance of flow cytometry derived EOI-MRD of <0.01% are emerging. Consecutive pediatric B-ALL patient...
Karthik Bommannan, V. Radhakrishnan, S. Sundersingh· Cytometry. Part B, Clinical...· 0 citations
Although DDT is currently banned in most countries of the world, this substance continues to pose a potential health risk and might partially contribute to the incidence of ALL.
R. Ugalde-Resano, Ángel Mérida-Ortega, Mariano E. Cebrián et al.· Cancer Epidemiology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.